# Hemant Surgical Industries Ltd (HSIL)
> Exchange: NSE | Sector: Healthcare | ISIN: 

## Price
Current Price: ₹407.7
Day Change: +4.32%
52W High: ₹422.85
52W Low: ₹89.99
Market Cap: ₹532 Cr

## Valuation
P/E: 56.78
P/B: 3.51
EPS: ₹7.18
Book Value: ₹116.16
Dividend Yield: 0%

## Returns
1Y Return: 318.15%

## Profitability
ROE: 80%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Hemant Surgical Industries Ltd is a Medical Devices company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Healthcare
Industry: Medical Devices
Sub Industry: Unknown

## Business Model
Overview: Hemant Surgical Industries Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Devices. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Healthcare.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Allotment
- Announcement: Intimation Of Appointment Of Cost Auditor
- BSE Filing: Announcement under Regulation 30 (LODR)-Allotment

## Data Freshness
Quote Updated: 2026-05-17T02:31:01.490Z
Price History Updated: 2026-05-18T22:59:20.305Z
Latest Price History Date: 2026-05-15
Technicals Updated: 2026-05-18T22:59:20.305Z
Quant Updated: 2026-05-18T22:59:20.305Z
Sentiment Updated: 2026-05-18T22:59:20.305Z
Financials Status: current
Financials Updated: 2026-05-18T11:30:01.208Z
Financials Last Attempt: 2026-05-18T11:30:01.208Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2026)
Revenue: ₹107 Cr
Operating Profit: ₹9 Cr (OPM 9%)
Net Profit: ₹8 Cr
Tax: ₹10 Cr

## Balance Sheet (Mar 2026)
Total Assets: ₹148 Cr
Total Liabilities: ₹148 Cr
Borrowings: ₹31 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/hsil
Disclaimer: For research and education only. Not investment advice.